FIELD: medicine; urology; neurourology.
SUBSTANCE: invention can be used for conservative treatment of overactive bladder syndrome. The patient takes 30 mg of Dapoxetine in the morning by mouth for one month.
EFFECT: method allows to effectively reduce the amount of urination, eliminate the appearance of imperative urges and increase the functional volume of urination with fewer side effects compared to other SSRIs by blocking the reuptake of serotonin from the synaptic cleft, and also provides a systemic nature of the treatment of overactive bladder due to the action drug at the level of the central nervous system.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINED NON-INVASIVE TREATMENT OF DETRUSOR HYPERACTIVITY IN PATIENTS AFTER PROSTATE TRANSURETRAL RESECTION | 2023 |
|
RU2804515C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| METHOD FOR CORRECTING NEUROGENIC DYSFUNCTION OF THE LOWER URINARY TRACT OF CENTRAL ORIGIN | 2021 |
|
RU2766762C1 |
| METHOD OF TREATING CHILDREN SUFFERING NEUROGENIC BLADDER DYSFUNCTION WITH DECREASED URINATE ACTIVITY BY BIOLOGICAL FEEDBACK | 2010 |
|
RU2452531C1 |
| COMPOSITION FOR TREATMENT AND/OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS | 2020 |
|
RU2808426C2 |
| METHOD OF TREATING THE NEUROGENIC BLADDER | 2020 |
|
RU2743805C1 |
| DRUG DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER VOIDING DYSFUNCTION AND OTHER LOWER URINARY TRACT DISORDERS BY USING TROSPIUM | 2013 |
|
RU2670749C9 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO CHRONIC PELVIC PAIN SYNDROME TREATMENT | 2018 |
|
RU2692644C1 |
| TREATMENT METHOD OF A HYPERACTIVE URINARY BUBBLE | 2017 |
|
RU2644304C1 |
| METHOD OF PREDICTING FORMATION OF COMPLICATIONS IN CASE OF HYPERACTIVE URINARY BLADDER IN CHILDREN | 2012 |
|
RU2497455C1 |
